These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 16358965

  • 1. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E, Ossolińska M, Naumnik W, Trojan S, Chyczewska E.
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W, Izycki T, Ossolinska M, Chyczewska E.
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [Abstract] [Full Text] [Related]

  • 4. [The value of serum endostatin level in early diagnosis of lung cancer].
    Xu AH, Yin YW, Chen FH.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 18; 86(27):1916-8. PubMed ID: 17064531
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer.
    Iizasa T, Chang H, Suzuki M, Otsuji M, Yokoi S, Chiyo M, Motohashi S, Yasufuku K, Sekine Y, Iyoda A, Shibuya K, Hiroshima K, Fujisawa T.
    Clin Cancer Res; 2004 Aug 15; 10(16):5361-6. PubMed ID: 15328173
    [Abstract] [Full Text] [Related]

  • 6. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
    Qin J, Zhang PH, Qian XY, Kang SJ, Luo RC, Wang YG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun 15; 28(6):930-2. PubMed ID: 18583230
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
    Naumnik W, Izycki T, Swidzińska E, Ossolińiska M, Chyczewska E.
    Oncol Res; 2007 Jun 15; 16(9):445-51. PubMed ID: 18074680
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T, Chyczewska E, Naumnik W, Talalaj J, Panek B, Ossolinska M.
    Exp Oncol; 2004 Dec 15; 26(4):316-9. PubMed ID: 15627066
    [Abstract] [Full Text] [Related]

  • 10. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
    Li R, Li R, Wang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan 15; 21(1):26-9. PubMed ID: 11263296
    [Abstract] [Full Text] [Related]

  • 11. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
    Cancer Invest; 2006 Oct 15; 24(6):576-80. PubMed ID: 16982461
    [Abstract] [Full Text] [Related]

  • 12. The detection of quantitative serum p53 protein in lung cancer.
    Sen E, Gönüllü U, Akar N.
    Tuberk Toraks; 2005 Oct 15; 53(3):231-7. PubMed ID: 16258881
    [Abstract] [Full Text] [Related]

  • 13. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
    Hu Y, Hu MM, Shi GL, Han Y, Li BL.
    Eur J Surg Oncol; 2014 Sep 15; 40(9):1136-42. PubMed ID: 24998915
    [Abstract] [Full Text] [Related]

  • 14. [The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients].
    Kopczyńska E, Dancewicz M, Kowalewski J, Kardymowicz H, Tyrakowski T.
    Pol Merkur Lekarski; 2007 Jun 15; 22(132):539-41. PubMed ID: 17874625
    [Abstract] [Full Text] [Related]

  • 15. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA, Brooks KR, Joshi MB, Conlon D, Herndon J, Petersen RP, Harpole DH.
    Ann Thorac Surg; 2006 Jun 15; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH, Zhao JH, Gong JP, Qin JW, Pan LQ, Xu ZY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 15; 29(3):210-4. PubMed ID: 17649639
    [Abstract] [Full Text] [Related]

  • 20. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
    Kanoh Y, Ohara T, Mashiko T, Abe T, Masuda N, Akahoshi T.
    Anticancer Res; 2006 Mar 15; 26(6B):4293-7. PubMed ID: 17201147
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.